Amsterdam, Netherlands

Erica Van Tilburg


Average Co-Inventor Count = 2.0

ph-index = 2

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2006-2007

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations by Erica Van Tilburg: Pioneering Adenosine Derivatives

Introduction

Erica Van Tilburg is a renowned inventor based in Amsterdam, Netherlands. With a strong focus on the field of medicinal chemistry, she has contributed significantly to the development of novel adenosine derivatives. Over her career, she has been granted three patents that highlight her innovative approaches to therapeutic applications.

Latest Patents

Erica's latest inventions focus on two key types of adenosine derivatives. The first patent discusses C2,5'-disubstituted and N,C2,5'-trisubstituted adenosine derivatives. These compounds have shown promise as potent adenosine receptor agonists, which are valuable in treating diseases and disorders related to adenosine receptor activity.

The second patent centers on C2,8-disubstituted adenosine derivatives, which also display significant biological activity, particularly against conditions such as hypertension, ischemic heart disease, and even psychosis and wound healing. Her work also includes a process for preparing these compounds and pharmaceutical compositions that contain them.

Career Highlights

Throughout her career, Erica Van Tilburg has been affiliated with prestigious institutions such as Leiden University, where she likely honed her research skills and innovative spirit. Her contributions have not only advanced academic knowledge but have also had real-world implications in pharmaceuticals and therapy.

Collaborations

One notable collaboration in her career is with Ad Ijzerman, who has worked alongside her in various research endeavors. Their combined expertise has certainly enriched the projects and patents they have developed together.

Conclusion

In conclusion, Erica Van Tilburg is an exemplary inventor whose work on adenosine derivatives is paving the way for new therapeutic options. Her patents demonstrate a deep understanding of medicinal chemistry and its potential to address critical health issues. As advancements continue in her field, her contributions will likely remain influential in future innovations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…